Lycia Therapeutics: Funding, Investors & Team (Oct 2026)
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.
Lycia Therapeutics has raised $145M across 2 funding rounds on record, the most recent a Series D of $75.0M announced in Jun 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Lycia Therapeutics Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Lycia Therapeutics Funding Rounds
Lycia Therapeutics raised $70.0M in a Series B announced in Sep 2021.
4.8 years later, a Series D of $75.0M was announced in Jun 2026.
Lycia Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Lycia Therapeutics Funding Compared to Other Biotechnology Startups
Lycia Therapeutics' latest round of $75.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lycia Therapeutics in Biotechnology and San Diego
Companies Similar to Lycia Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Lycia Therapeutics Funding FAQs
What does Lycia Therapeutics do?
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras. The company was founded by Carolyn R. Bertozzi in 2019 and is based in San Diego, California, USA.
How much funding has Lycia Therapeutics raised?
Lycia Therapeutics has raised $145M across 2 rounds on record. The most recent is a Series D of $75.0M announced in Jun 2026.
When did Lycia Therapeutics last raise funding?
Lycia Therapeutics' most recent funding round on record is a Series D of $75.0M, announced in Jun 2026.
Who founded Lycia Therapeutics?
FundedIQ lists Aetna Wun (Founder) at Lycia Therapeutics.
Who is the CEO of Lycia Therapeutics?
Aetna Wun Trombley is listed as CEO at Lycia Therapeutics.
Where is Lycia Therapeutics headquartered?
Lycia Therapeutics is based in San Diego, California, United States.
How many employees does Lycia Therapeutics have?
Lycia Therapeutics is in the 11-50 employee band.
How does Lycia Therapeutics' funding compare to other Biotechnology startups?
Lycia Therapeutics' latest round of $75.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Lycia Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lycia Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.